InvestorsHub Logo
Followers 59
Posts 6123
Boards Moderated 0
Alias Born 03/04/2011

Re: MD-420 post# 1008

Wednesday, 12/06/2017 11:57:51 AM

Wednesday, December 06, 2017 11:57:51 AM

Post# of 2676
Shares of Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE), a specialty pharmaceutical company that focuses on developing and commercializing pharmaceutically produced transdermal cannabinoid treatments, traded higher during Monday's pre-market session but then sold off after the opening bell.

The company's update on a clinical trial may have been overshadowed by GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH)'s earnings report, in which the larger cannabinoid therpauetics company reported a $175.9-million loss on sales of $11 million.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZYNE News